| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |